Publicaciones en las que colabora con María José Calasanz Abinzano (16)

2020

  1. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data

    Leukemia Research, Vol. 95

2019

  1. Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated

    Haematologica, Vol. 104, Núm. 8, pp. 1572-1579

2015

  1. CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

    Haematologica

2013

  1. Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms

    Haematologica, Vol. 98, Núm. 9, pp. 1414-1420

2012

  1. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 7, pp. 1517-1526

  2. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

    PLoS ONE, Vol. 7, Núm. 2

2011

  1. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family

    British Journal of Haematology, Vol. 155, Núm. 1, pp. 73-83

  2. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in Acute Lymphoblastic Leukemia

    PLoS ONE, Vol. 6, Núm. 2

2010

  1. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

    Blood, Vol. 115, Núm. 3, pp. 615-625

2009

  1. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

    Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453

1998

  1. Emergence of secondary acute leukemia in a patient treated for osteosarcoma: Implications of germline TP53 mutations

    Medical and Pediatric Oncology, Vol. 30, Núm. 3, pp. 165-169

1997

  1. Estudio clínico y evolutivo de la leucemia de células plasmáticas. A propósito de nueve casos

    Revista Clinica Espanola, Vol. 197, Núm. 5, pp. 341-345

1994

  1. Complex karyotype including 14q+ marker in a case of Waldenström's macroglobulinemia

    Cancer Genetics and Cytogenetics, Vol. 73, Núm. 2, pp. 169-170

  2. Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters

    Cancer Genetics and Cytogenetics, Vol. 78, Núm. 2, pp. 210-213

1992

  1. A new case of acute lymphoblastic leukemia B‐cell type with chromosomal rearrangements involving the T‐cell receptor breakpoint at band 14q11

    American Journal of Hematology, Vol. 41, Núm. 2, pp. 137-139

  2. Cytogenetic marker del(12p) in a case of acute myeloid leukemia M4 with eosinophilia and inv(16)

    Sangre, Vol. 37, Núm. 2, pp. 125-127